160 related articles for article (PubMed ID: 27860539)
1. Epitope-Specific Antitumor Immunity Suppresses Tumor Spread in Papillary Thyroid Cancer.
Ehlers M; Kuebart A; Hautzel H; Enczmann J; Reis AC; Haase M; Allelein S; Dringenberg T; Schmid C; Schott M
J Clin Endocrinol Metab; 2017 Jul; 102(7):2154-2161. PubMed ID: 27860539
[TBL] [Abstract][Full Text] [Related]
2. Evidence of a combined cytotoxic thyroglobulin and thyroperoxidase epitope-specific cellular immunity in Hashimoto's thyroiditis.
Ehlers M; Thiel A; Bernecker C; Porwol D; Papewalis C; Willenberg HS; Schinner S; Hautzel H; Scherbaum WA; Schott M
J Clin Endocrinol Metab; 2012 Apr; 97(4):1347-54. PubMed ID: 22259066
[TBL] [Abstract][Full Text] [Related]
3. T cell exhaustion is associated with the risk of papillary thyroid carcinoma and can be a predictive and sensitive biomarker for diagnosis.
Zhu C; Dai Y; Zhang H; Ruan Y; Zhou Y; Dai Y; Fan L; Jia T; Lu H; Chen Q
Diagn Pathol; 2021 Aug; 16(1):84. PubMed ID: 34465342
[TBL] [Abstract][Full Text] [Related]
4. BRAFV600E and BRAF-WT Specific Antitumor Immunity in Papillary Thyroid Cancer.
Ehlers M; Schmidt M; Mattes-Gyorgy K; Antke C; Enczmann J; Schlensog M; Japp A; Haase M; Allelein S; Dringenberg T; Giesel F; Esposito I; Schott M
Horm Metab Res; 2022 Dec; 54(12):852-858. PubMed ID: 36427494
[TBL] [Abstract][Full Text] [Related]
5. Association between the HLA-G molecule and lymph node metastasis in papillary thyroid cancer.
Nunes LM; Ayres FM; Francescantonio IC; Saddi VA; Avelino MA; Alencar Rde C; Silva RC; Meneghini AJ; Wastowski IJ
Hum Immunol; 2013 Apr; 74(4):447-51. PubMed ID: 23261411
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic value of tumor-infiltrating B cells in lymph node metastases of papillary thyroid carcinoma.
Yang Z; Yin L; Zeng Y; Li Y; Chen H; Yin S; Zhang F; Yang W
Virchows Arch; 2021 Nov; 479(5):947-959. PubMed ID: 34148127
[TBL] [Abstract][Full Text] [Related]
7. Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer.
French JD; Weber ZJ; Fretwell DL; Said S; Klopper JP; Haugen BR
J Clin Endocrinol Metab; 2010 May; 95(5):2325-33. PubMed ID: 20207826
[TBL] [Abstract][Full Text] [Related]
8. Is human leukocyte antigen-DR and intercellular adhesion molecule-1 expression on human thyrocytes constitutive in papillary thyroid cancer? Comparative studies in human thyroid xenografts in severe combined immunodeficient and nude mice.
Kawai K; Resetkova E; Enomoto T; Fornasier V; Volpé R
J Clin Endocrinol Metab; 1998 Jan; 83(1):157-64. PubMed ID: 9435434
[TBL] [Abstract][Full Text] [Related]
9. Characterization of thyroglobulin epitopes in patients with autoimmune and non-autoimmune thyroid diseases using recombinant human monoclonal thyroglobulin autoantibodies.
Latrofa F; Ricci D; Grasso L; Vitti P; Masserini L; Basolo F; Ugolini C; Mascia G; Lucacchini A; Pinchera A
J Clin Endocrinol Metab; 2008 Feb; 93(2):591-6. PubMed ID: 18029466
[TBL] [Abstract][Full Text] [Related]
10. Chronic lymphocytic thyroiditis (CLT) has a positive prognostic value in papillary thyroid cancer (PTC) patients: the potential key role of Foxp3+ T lymphocytes.
Pilli T; Toti P; Occhini R; Castagna MG; Cantara S; Caselli M; Cardinale S; Barbagli L; Pacini F
J Endocrinol Invest; 2018 Jun; 41(6):703-709. PubMed ID: 29230715
[TBL] [Abstract][Full Text] [Related]
11. Hashimoto's thyroiditis and papillary thyroid cancer: are they immunologically linked?
Ehlers M; Schott M
Trends Endocrinol Metab; 2014 Dec; 25(12):656-64. PubMed ID: 25306886
[TBL] [Abstract][Full Text] [Related]
12. Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin.
Latrofa F; Ricci D; Montanelli L; Rocchi R; Piaggi P; Sisti E; Grasso L; Basolo F; Ugolini C; Pinchera A; Vitti P
J Clin Endocrinol Metab; 2012 Jul; 97(7):2380-7. PubMed ID: 22539585
[TBL] [Abstract][Full Text] [Related]
13. IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto's thyroiditis.
Han LT; Hu JQ; Ma B; Wen D; Zhang TT; Lu ZW; Wei WJ; Wang YL; Wang Y; Liao T; Ji QH
Diagn Pathol; 2019 Jun; 14(1):52. PubMed ID: 31159823
[TBL] [Abstract][Full Text] [Related]
14. IL-10 Restores MHC Class I Expression and Interferes With Immunity in Papillary Thyroid Cancer With Hashimoto Thyroiditis.
Lu ZW; Hu JQ; Liu WL; Wen D; Wei WJ; Wang YL; Wang Y; Liao T; Ji QH
Endocrinology; 2020 Oct; 161(10):. PubMed ID: 32348468
[TBL] [Abstract][Full Text] [Related]
15. MHC class I loss is a frequent mechanism of immune escape in papillary thyroid cancer that is reversed by interferon and selumetinib treatment in vitro.
Angell TE; Lechner MG; Jang JK; LoPresti JS; Epstein AL
Clin Cancer Res; 2014 Dec; 20(23):6034-44. PubMed ID: 25294906
[TBL] [Abstract][Full Text] [Related]
16. Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma.
Vasileiadis I; Boutzios G; Charitoudis G; Koukoulioti E; Karatzas T
Ann Surg Oncol; 2014 Aug; 21(8):2725-32. PubMed ID: 24595799
[TBL] [Abstract][Full Text] [Related]
17. HLA class II expression in well differentiated thyroid carcinoma: correlation with clinicopathological features.
Knoll MR; Schwab M; Oestreich K; Rumstadt B; Hagmüller E
J Exp Clin Cancer Res; 1997 Jun; 16(2):177-82. PubMed ID: 9261744
[TBL] [Abstract][Full Text] [Related]
18. The Clinical Relevance of Psammoma Body and Hashimoto Thyroiditis in Papillary Thyroid Carcinoma: A Large Case-control Study.
Cai YF; Wang QX; Ni CJ; Guo GL; Li Q; Wang OC; Wu L; Du HY; You J; Zhang XH
Medicine (Baltimore); 2015 Nov; 94(44):e1881. PubMed ID: 26554782
[TBL] [Abstract][Full Text] [Related]
19. Papillary thyroid carcinoma patients assessed to be at low or intermediary risk after primary treatment are at greater risk of long term recurrence if they are thyroglobulin antibody positive or do not have distinctly low thyroglobulin at initial assessment.
Soyluk O; Boztepe H; Aral F; Alagol F; Özbey NC
Thyroid; 2011 Dec; 21(12):1301-8. PubMed ID: 22136265
[TBL] [Abstract][Full Text] [Related]
20. Thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: comparison of different assays and evaluation of causes of discrepancies.
Latrofa F; Ricci D; Montanelli L; Rocchi R; Piaggi P; Sisti E; Grasso L; Basolo F; Ugolini C; Pinchera A; Vitti P
J Clin Endocrinol Metab; 2012 Nov; 97(11):3974-82. PubMed ID: 22948755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
